Oxford Covid-19 vaccine produces strong immune response in older adults, study finds
Published
Published
The University of Oxford is working on the latest trial of the ChAdOx1 nCov-2019 vaccine.
The ChAdOx1 nCov-2019 vaccine has been shown to trigger a robust immune response